Skip to main content
    P

    P3 Health Partners Inc (PIII)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $2.19
    -0.22 (-9.13%)

    Last updated: Nov 17, 2026 at 4:00 PM ET

    P3 Health Partners Inc (PIII) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    P3 Health Partners (PIII) has a market cap of $7.44M and an enterprise value of $85.41M. Its net debt of $77.96M equals 1047.35% of its market cap. Its share count is up 4.01% from a year earlier.

    Total Valuation

    Enterprise value is 1047.35% above the market cap, as debt exceeds cash.

    Market Cap$7.44M
    Enterprise Value$85.41M
    Close (Nov 17, 2026)$2.19

    Key Dates

    The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 24, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.10% in the quarter ended Sep 30, 2026 and grew 2.46% a year over 2 years.

    Shares Outstanding3.40M
    Other Share ClassesPIIIW
    Shares Change (YoY)+4.01%
    Shares Change (QoQ)+1.10%
    Share Count Growth (2Y CAGR)+2.46%

    Price Statistics

    The stock is down 67.98% over 52 weeks and trades 58.37% below its 50-day average.

    Beta (1Y)-0.47
    52-Week Change-67.98%
    1-Month Change-42.52%
    3-Month Change-78.68%
    6-Month Change-79.12%
    5-Year Change-99.19%
    Total Return (1Y)-67.98%
    Total Return (3Y CAGR)-66.91%
    Total Return (5Y CAGR)-66.24%
    Return vs SPY (1Y)-77.34%
    Max Drawdown (1Y)-86.70%
    Max Drawdown (3Y)-98.25%
    Sharpe Ratio (1Y)-0.66
    Correlation with SPY (1Y)-0.04
    50-Day Average$5.26
    200-Day Average$6.60
    52-Week Range$1.52 to $16.89
    RSI (14 Days)24.8
    Average Volume (20 Days)58.28K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.53x current liabilities, and total debt is 1.14x shareholder equity.

    Current Ratio0.53x
    Quick Ratio0.53x
    Debt / Equity1.14x
    Debt / EBITDA14.77x
    Interest Coverage-1.80x

    Returns and Efficiency

    Return on invested capital is -32.57% over the last 12 months, against a 5-year average of -20.00%.

    Return on Equity (ROE)-108.36%
    Return on Assets (ROA)-17.36%
    Return on Invested Capital (ROIC)-32.57%
    Return on Capital Employed (ROCE)-30.99%
    ROIC (5Y Average)-20.00%
    Asset Turnover2.30x

    Scores

    PIII has an Altman Z-Score of 0.28, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score0.28
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.55B over the last 12 months is up 10.71% from the 12 months before.

    Revenue$1.55B
    Revenue Growth (YoY)+10.71%
    Gross Profit$1.55B
    Operating Income-$81.42M
    Pretax Income-$127.00M
    Net Income-$116.25M
    EBITDA$8.25M
    EBIT-$81.53M
    Reported EPS (TTM)-$23.26

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 16.02% of the $669.72M in total assets.

    Cash and Equivalents$43.90M
    Total Debt$121.86M
    Net Debt$77.96M
    Net Debt Per Share$22.94
    Working Capital-$190.62M
    Shareholder Equity$107.27M
    Tangible Book Value-$324.55M
    Total Assets$669.72M
    Total Liabilities$469.00M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$115.79M
    FCF Per Share-$29.65
    Depreciation and Amortization$89.77M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -5.24%.

    Gross Margin100.00%
    Operating Margin-5.24%
    Pretax Margin-8.17%
    Net Margin-7.48%
    EBITDA Margin0.53%
    EBIT Margin-5.25%

    Growth

    Revenue grew 11.61% a year over 3 years.

    Revenue Growth (3Y CAGR)+11.61%
    Revenue Growth (5Y CAGR)+24.33%

    Revenue and profit by year

    Dividends and Yields

    PIII does not pay a dividend.

    Buyback Yield-145.36%
    Shareholder Yield-145.36%

    Stock Splits

    The last split was a 1-for-50 reverse split on Apr 14, 2025.

    Last Split DateApr 14, 2025
    Split TypeReverse split
    Split Ratio1:50

    Peer Position

    Against 10 similar companies, PIII has the 10th highest ROIC.

    ROIC-32.57% vs 10.92% median
    Revenue Growth (Trailing 4 Quarters, YoY)+10.71% vs +10.71% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.49% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.49%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PIII

    What is PIII's market cap?

    P3 Health Partners has a market cap of $7.44M. Its enterprise value, which adds debt and subtracts cash, is $85.41M.

    How many shares of PIII are outstanding?

    P3 Health Partners has 3.40M shares outstanding. The count is up 4.01% from a year earlier.

    Does PIII pay a dividend?

    No. P3 Health Partners does not pay a dividend.

    How much debt does PIII have?

    P3 Health Partners has $121.86M of total debt and $43.90M of cash and equivalents, a net debt position of $77.96M.